I await evidence that regenerating IHCs alone (the straw you're clutching at to suggest FX-322 is still efficacious) will assist with tinnitus.You only have word score troubles when you lose a lot of IHCs.
I await evidence that regenerating IHCs alone (the straw you're clutching at to suggest FX-322 is still efficacious) will assist with tinnitus.You only have word score troubles when you lose a lot of IHCs.
That's better than what I was thinking because they actually did it? We probably already have the technologies although integrating them is a whole other story. With the pace of the FDA process, maybe in my lifetime, I will see something.This looks similar to what you are suggesting:
Steady streaming as a method for drug delivery to the inner ear
There's also cochlear pumping, which looks more promising to me in the mechanical category:
Local Drug Delivery to the Entire Cochlea without Breaching Its Boundaries
That's not even my position though. I think it prefers IHCs, not that it can only grow IHCs.I await evidence that regenerating IHCs alone (the straw you're clutching at to suggest FX-322 is still efficacious) will assist with tinnitus.
You only have word score troubles when you lose a lot of IHCs.
This is why I think they were inadvertently selecting for "the unconscious biasers". Because you need people not in the severe range on audiogram (OHCs) but who happen to have lost a lot of IHCs. That's not usually how it works naturally...
Words in noise is very correlated to synaptopathy btw, which is separate from IHC loss and OHC loss.
I'm fine with words in noise if I'm on the same table as the person talking to me but I probably would not be able to hear conversation across the room, maybe that would be normal for a person, so I don't have trouble with words in noise anyway.You could also have synaptopathy if you struggle a lot with speech in noise issues.
Everyone reading this right now...You're not understanding how this works. If Phase 2a was a success, the doubters knew all along. If it was a failure, it's all your fault. If Phase 2a results were a slam dunk, it overrides Phase 1. Since it's not, Phase 1 is the real efficacy test. If an audiologist agrees with you, it means you're right. If they disagree with you, it's because they are trying to sabotage the regeneration medicine industry.
If it turns out all of the 3 super responders were legit, I'm going to pretend like I never questioned how it happened. If the second Phase 2 is successful, I'm going to say that I was intentionally a bear to challenge our beliefs -- please thank me. If it's a failure, I'm going to say that I was so smart.
Any placebo patients that improve are diabolic lunatics, plotting to destroy the operation. Any FX-322 patients that improve are choir boys, have never uttered a swear word before, and gleefully showed off their improved hearing signal that was cleaner than a baby's bottom.
If someone's tinnitus got better, it was from the drug, but if it got worse, it was from the evil clinician who injured their middle ear.
If people enjoy this post, it's because I'm clever. If not, it's because I wasn't being serious.
No, your blue ear doesn't average a PTA of 71-90 dB. But you probably would have gotten into the Phase 2A.This is my audiogram. Do you think I would qualify for the severe hearing loss trial?
View attachment 44344
Did you read this? RIP to anyone with hyperacusis.This looks similar to what you are suggesting:
Steady streaming as a method for drug delivery to the inner ear
There's also cochlear pumping, which looks more promising to me in the mechanical category:
Local Drug Delivery to the Entire Cochlea without Breaching Its Boundaries
Do you think my word score was bad enough for Phase 2a?No, your blue ear doesn't average a PTA of 71-90 dB. But you probably would have gotten into the Phase 2A.
It's going to suck if a repeat of Phase 2 approaches and I legitimately start believing in its success again. Right now, it's super easy to be a bear. I'm like a band wagon bear.
Obviously you could have faked it... pfffft.Do you think my word score was bad enough for Phase 2a?
Same people calling you names and saying "IT DOESN'T WORK!" will then be saying, "IT DOES WORK!" and still calling you names...It's going to suck if a repeat of Phase 2 approaches and I legitimately start believing in its success again. Right now, it's super easy to be a bear. I'm like a band wagon bear.
When things eventually start succeeding with hearing regeneration (who knows how long that will be?), I'm going to be against the world.
"Zugzug, how do you explain that that none of the placebos improved and 85% of the treated group has clinically meaningful improvements in WR, WIN, and PTA?"
I'll have to come back over if I am check mated and literally can't come up with a bear argument. I don't see this happening anytime soon though.
They never published their criteria but apparently people weren't taking chances...Do you think my word score was bad enough for Phase 2a?
Anecdotes.We have some tinnitus anecdotes. Look forward to hearing more.
Well until we get an objective measure of tinnitus, unfortunately all we have is patient input...Anecdotes.
If they were given sugar pills, with tinnitus, there would be anecdotes.
Another 3-6 months of waiting trial results :'(Well until we get an objective measure of tinnitus, unfortunately all we have is patient input...
Why is this method not being utilized?This looks similar to what you are suggesting:
Steady streaming as a method for drug delivery to the inner ear
There's also cochlear pumping, which looks more promising to me in the mechanical category:
Local Drug Delivery to the Entire Cochlea without Breaching Its Boundaries
What were the adverse events?By the way, they observed a significant higher rate of adverse events in higher injections cohorts. Phase 2a single injections were safer, but were also found to have more adverse events compared to Phases 1/1b/1-2 single injections.
They just said that multiple dosing is not a viable option, literally.
There were no side effects with the multi-dosing, just that it wasn't as effective as the single dosing in Phase 1b.What were the adverse events?
They didn't say that, only that no side effects were serious. They did say there were more side effects in the Phase 2a dosing though.There were no side effects with the multi-dosing, just that it wasn't as effective as the single dosing in Phase 1b.
I didn't know they said that, my bad.They didn't say that, only that no side effects were serious. They did say there were more side effects in the Phase 2a dosing though.
I think you mean Frequency Therapeutics scientists fix it. I doubt if any of their scientists read this thread for any advice. If the drug isn't dead you should be loading up on FREQ stock at these low levels. It might be cheap for a reason. Time will tell.To some this means "the drug is dead". To others (including myself) it means "the drug is flawed. So let's fix it if we can".
Looks to me like it takes about 5 hours to reach the deep parts. You'd have to lay there for 5 hours with this thing in your ear. I would do it. Maybe they can knock you out first or they can refine the process to speed it up.Why is this method not being utilized?
No treatment-related serious adverse events were observed in the study.I didn't know they said that, my bad.
Good oneYou're not understanding how this works. If Phase 2a was a success, the doubters knew all along. If it was a failure, it's all your fault. If Phase 2a results were a slam dunk, it overrides Phase 1. Since it's not, Phase 1 is the real efficacy test. If an audiologist agrees with you, it means you're right. If they disagree with you, it's because they are trying to sabotage the regeneration medicine industry.
If it turns out all of the 3 super responders were legit, I'm going to pretend like I never questioned how it happened. If the second Phase 2 is successful, I'm going to say that I was intentionally a bear to challenge our beliefs -- please thank me. If it's a failure, I'm going to say that I was so smart.
Any placebo patients that improve are diabolic lunatics, plotting to destroy the operation. Any FX-322 patients that improve are choir boys, have never uttered a swear word before, and gleefully showed off their improved hearing signal that was cleaner than a baby's bottom.
If someone's tinnitus got better, it was from the drug, but if it got worse, it was from the evil clinician who injured their middle ear.
If people enjoy this post, it's because I'm clever. If not, it's because I wasn't being serious.
If the age-related and severe hearing loss trials have positive outcomes, I expect the share price to go up to $20. If they announce a pivotal phase, the share price will go back up to $60 or more. At the current price the stock is a bargain.I think you mean Frequency Therapeutics scientists fix it. I doubt if any of their scientists read this thread for any advice. If the drug isn't dead you should be loading up on FREQ stock at these low levels. It might be cheap for a reason. Time will tell.